Eine leistungsstarke Nachrichten-API, die saubere, angereicherte und sofort einsatzbereite globale Nachrichtendaten aus über 90.000 Quellen liefert. Sie ermöglicht Entwicklern und Unternehmen, Nachrichten mit erweiterter Filterung, Clustering und Echtzeit-Einblicken für verschiedene Anwendungen zu suchen, zu verfolgen und zu analysieren.
Oxylabs ist ein führender Anbieter von Premium-Proxy-Diensten und Web-Datenerfassungslösungen auf Unternehmensebene. Durch die Nutzung eines riesigen, ethisch einwandfreien Proxy-Netzwerks mit über 177 Millionen IPs bietet es KI-gestützte Scraper-APIs, einen Web-Unblocker und das neue AI Studio zur Extraktion von Daten in natürlicher Sprache. Es ermöglicht Unternehmen, öffentliche Webdaten in großem Umfang für E-Commerce, Cybersicherheit, Markenschutz und Marktforschung zu sammeln, ohne blockiert zu werden.
Produktübersicht
newscatcherapi Produktübersicht
Eine leistungsstarke Nachrichten-API, die saubere, angereicherte und sofort einsatzbereite globale Nachrichtendaten aus über 90.000 Quellen liefert. Sie ermöglicht Entwicklern und Unternehmen, Nachrichten mit erweiterter Filterung, Clustering und Echtzeit-Einblicken für verschiedene Anwendungen zu suchen, zu verfolgen und zu analysieren.
Oxylabs Produktübersicht
Oxylabs ist ein führender Anbieter von Premium-Proxy-Diensten und Web-Datenerfassungslösungen auf Unternehmensebene. Durch die Nutzung eines riesigen, ethisch einwandfreien Proxy-Netzwerks mit über 177 Millionen IPs bietet es KI-gestützte Scraper-APIs, einen Web-Unblocker und das neue AI Studio zur Extraktion von Daten in natürlicher Sprache. Es ermöglicht Unternehmen, öffentliche Webdaten in großem Umfang für E-Commerce, Cybersicherheit, Markenschutz und Marktforschung zu sammeln, ohne blockiert zu werden.
Detailed feature comparison
| Feature | newscatcherapi | Oxylabs |
|---|---|---|
| Hauptkategorie | Marktintelligenz | Marktintelligenz |
| Hinzugefügt | 2025-08-05 | 2025-08-15 |
| Preismodell | Kostenpflichtig | Kostenpflichtig |
| Offizielle Website | www.newscatcherapi.com | oxylabs.io |
| Produkttyp | Website | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 29.2K | 481.1K |
| Monatliches Wachstum | -3.1% | -6% |
| Favoriten | 132 | 141 |
| Details | Details ansehen | Details ansehen |
newscatcherapi vs Oxylabs monthly traffic
Compare newscatcherapi and Oxylabs by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the newscatcherapi vs Oxylabs monthly traffic comparison, newscatcherapi currently shows 29.2K visits and Oxylabs shows 481.1K; Oxylabs has about 16.5 times the visible traffic of newscatcherapi, an absolute difference of about 451.9K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
newscatcherapi monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 37.4K Monatliche Besuche
- 2026/1: 25.9K Monatliche Besuche
- 2026/2: 21.3K Monatliche Besuche
- 2026/3: 29.9K Monatliche Besuche
- 2026/4: 30.1K Monatliche Besuche
- 2026/5: 29.2K Monatliche Besuche
Top-Regionen
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 41.38% | 12.1K |
| 🇮🇳India | 20.75% | 6.1K |
| 🇻🇳Vietnam | 15.11% | 4.4K |
| 🇳🇬Nigeria | 13.01% | 3.8K |
| 🇩🇪Germany | 9.75% | 2.8K |
Traffic-Quellen
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 76.03% | 22.2K |
| Verweis | 23.97% | 7K |
Suchbegriffe
Oxylabs monthly traffic:
Latest traffic
Monthly traffic trend
- 2025/9: 517K Monatliche Besuche
- 2026/1: 662.2K Monatliche Besuche
- 2026/2: 500.1K Monatliche Besuche
- 2026/3: 500.4K Monatliche Besuche
- 2026/4: 512.1K Monatliche Besuche
- 2026/5: 481.1K Monatliche Besuche
Top-Regionen
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 62.35% | 300K |
| 🇮🇳India | 14.93% | 71.8K |
| 🇩🇪Germany | 7.84% | 37.7K |
| 🇨🇦Canada | 7.82% | 37.6K |
| 🇵🇰Pakistan | 7.06% | 34K |
Traffic-Quellen
| Source type | Percentage | Traffic |
|---|---|---|
| Direkt | 81.41% | 391.7K |
| Verweis | 11.68% | 56.2K |
| 6.91% | 33.2K |
Suchbegriffe
Usage comparison
Compare the core capabilities of newscatcherapi and Oxylabs
newscatcherapi Core features
Oxylabs Core features
Use cases
newscatcherapi Use cases
Oxylabs Use cases
newscatcherapi vs Oxylabs:In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth newscatcherapi vs Oxylabs comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. newscatcherapi is primarily listed under “Marktintelligenz”, while Oxylabs is primarily listed under “Marktintelligenz”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Monthly visits (newscatcherapi: 29.2K; Oxylabs: 481.1K); Monthly growth (newscatcherapi: -3.1%; Oxylabs: -6%); Favorites (newscatcherapi: 132; Oxylabs: 141); Website (newscatcherapi: www.newscatcherapi.com; Oxylabs: oxylabs.io); Added (newscatcherapi: 2025-08-05; Oxylabs: 2025-08-15). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the newscatcherapi vs Oxylabs monthly traffic comparison, newscatcherapi currently shows 29.2K visits and Oxylabs shows 481.1K; Oxylabs has about 16.5 times the visible traffic of newscatcherapi, an absolute difference of about 451.9K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate Oxylabs first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
Product positioning, use cases, and roles
newscatcherapi and Oxylabs currently overlap in shared categories: Marktintelligenz und API; shared tags: Datenerfassung und Marktforschung. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
newscatcherapi's unique categories/tags are Datenerfassung, Forschung, Wettbewerbsintelligenz, Datenanreicherung, Finanzdaten, globale Nachrichten, LLM-Training und Medienbeobachtung; Oxylabs's are Web Scraping, Automatisierung, KI-Daten, Datenextraktion, Entwickler-API, E-Commerce-Intelligenz, Proxy-Dienst und SERP-Monitoring. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
newscatcherapi has no verified rating, 0 comments, 132 favorites, and 132 likes;Oxylabs has no verified rating, 0 comments, 141 favorites, and 142 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate newscatcherapi first
Put newscatcherapi on the priority trial list when the task aligns with “Marktintelligenz” and especially Datenerfassung, Forschung, Wettbewerbsintelligenz, Datenanreicherung, Finanzdaten und globale Nachrichten. This follows recorded positioning and does not imply unlisted capabilities are absent.
newscatcherapi also currently records: pricing is paid, product type is website, 29.2K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Oxylabs first
Put Oxylabs on the priority trial list when the task aligns with “Marktintelligenz” and especially Web Scraping, Automatisierung, KI-Daten, Datenextraktion, Entwickler-API und E-Commerce-Intelligenz. This follows recorded positioning and does not imply unlisted capabilities are absent.
Oxylabs also currently records: pricing is paid, product type is website, 481.1K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in newscatcherapi and Oxylabs, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.




